Composition
- Active ingredients
- ETRIPAMIL 70MG
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA218571.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Cardamyst
- Active substance
- etripamil
- Route
- Nasal
- Dosage form
- Spray
- Applicant
- Milestone Pharms USA
- Status
- Prescription
- FDA approval
- 12 Dec 2025
- Application
- NDA218571-001



